Previous 10 | Next 10 |
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. About XLV. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For August
Due to uncertainties surrounding rising inflation and a resurgence of COVID-19 cases, the stock market remains volatile. Given this environment, investors are shifting toward quality growth stocks to dodge short-term market fluctuations. So, with this, we think growth stocks Danaher (DHR), Ho...
Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...
Hologic is a leading medical technology company that's carved out a niche in the Women's Health segment. It's making the most of its 'COVID windfall' through strategic acquisitions and share buybacks. I also highlight the balance sheet, valuation, and other points worth considerin...
Image source: The Motley Fool. Hologic, inc (NASDAQ: HOLX) Q3 2021 Earnings Call Jul 28, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Hologic, inc (HOLX) Q3 2021 Earnings Call Transcript
Hologic, Inc. (HOLX) Q3 2021 Earnings Conference Call July 28, 2021, 04:30 PM ET Company Participants Michael Watts - Vice President of Investor Relations and Corporate Communications Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer...
LaylaBird/E+ via Getty Images Hologic (HOLX) saw its Q3 2021 net income jump 95% to $268.4M ($1.04 per diluted share) due to a surge in revenue. In the quarter, the company had revenue of $1.17B, a 42.2% year-over-year increase that beat analysts expectations by $130M. Also, Q3 Non-GAAP ...
Hologic (HOLX): Q3 Non-GAAP EPS of $1.33 beats by $0.21; GAAP EPS of $1.04 beats by $0.14.Revenue of $1.17B (+42.2% Y/Y) beats by $130M.FQ4 2021 guidance: Revenue: $1,000 - $1,040M (consensus $1.03B); non-GAAP EPS: $0.92 - $1.00 (consensus $1.12): GAAP EPS: $0.63 - $0.71.Press ...
— Revenue of $1.168 Billion Increases 42.0%, 37.8% in Constant Currency — — Organic Revenue Increases 38.4%, 34.2% in Constant Currency — — Company Posts GAAP Diluted EPS of $1.04, Non-GAAP Diluted EPS of $1.33 — Hologic, Inc. (N...
With STIs reaching a new high for the sixth consecutive year, a more inclusive screening approach is considered for chlamydia and gonorrhea in women under 25 First CDC guidelines to recommend testing specific populations for Mycoplasma genitalium, which was previously listed a...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...